Healthcare Industry News: Solvay Pharmaceuticals
News Release - January 19, 2006
Solvay Pharmaceuticals Names Harold H. Shlevin, Ph.D., as Global Senior Vice PresidentMARIETTA, Ga.--(HSMN NewsFeed)--Jan. 19, 2006--Solvay Pharmaceuticals announced today the promotion of Harold H. Shlevin, Ph.D. to Global Senior Vice President of the newly formed global Regulatory, External Affairs, Safety and Quality Strategies (RESQS) organization effective Jan. 1, 2006 reporting to Dr. Werner Cautreels, global CEO of Solvay Pharmaceuticals. Shlevin formerly served as President and CEO of Solvay Pharmaceuticals, Inc., in the United States and is succeeded by Laurence Downey, MD.
Shlevin will continue to serve as a member of the board of directors for the U.S. pharmaceuticals organization and will assume additional responsibilities as a member of both the executive directors committee and the board of directors for the global Solvay Pharmaceuticals organization.
"The RESQS organization will align several important areas of the global Solvay Pharmaceuticals organization including global quality, global drug safety and surveillance, global regulatory affairs and external affairs," said Werner Cautreels, CEO, Solvay Pharmaceuticals. "Dr. Shlevin's experience and expertise is ideally suited to help structure the development and establishment of this newly-created organization."
An eight- year veteran of the company, Shlevin served as president and CEO of Solvay Pharmaceuticals, Inc. in the U.S. since 2000, resulting in record growth. Prior to this he was with CIBA Vision Ophthalmic and Ciba-Geigy Pharmaceuticals. He currently serves on the board of directors of the Pharmaceutical Research and Manufacturers Association of America, National Pharmaceutical Council, the American Foundation for Suicide Prevention, the board of visitors of Morehouse School of Medicine and the board of Cardiome Pharma.
Solvay Pharmaceuticals, Inc. (www.solvaypharmaceuticals-us.com) of Marietta, Georgia (USA) is a research-driven pharmaceutical company that seeks to fulfill unmet medical needs in the therapeutic areas of cardiology, gastroenterology, mental health, women's health and a select group of specialized markets including men's health. It is a part of the global Solvay Pharmaceuticals organization whose core activities consist of discovering, developing and manufacturing medicines for human use. Solvay Pharmaceuticals is a subsidiary corporation of the worldwide Solvay Group of chemical and pharmaceutical companies headquartered in Brussels, Belgium.
Source: Solvay Pharmaceuticals
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.